CNBC
As Sanofi's Pompe drug shortage drags on, some patients struggle to access treatments
Thursday, November 19, 2026
Sanofi's Pompe disease treatment has been in short supply, causing some patients to miss scheduled doses. Pompe disease is a rare genetic disorder affecting muscle function. The company has not announced a timeline for resolving the shortage.
Original reporting:
